Delivery Order SPE2DB20D2104-SPE2DB25FMFQA
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,714.20 Firm Fixed Price Delivery Order contract is for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,514,819 units of Candesartan Cilexetil 32 mg tablets. The firm-fixed-price delivery order, valued at $2,264.64, has a completion date of November 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,490.93, is for the delivery of Candesartan Cilexetil 16 mg tablets in quantities of 90 per bottle. It is a firm fixed-price delivery order contract that runs through January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,646.26 firm fixed-price delivery order is for the supply of 90-count bottles of 16 mg Candesartan Cilexetil tablets. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,670.22, is a Firm Fixed Price Delivery Order for the supply of Candesartan Cilexetil 8 mg tablets. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,481.49, is a firm fixed-price delivery order for the supply of 4,567,109,988 units of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,211.16, is for the delivery of 4,566,490,410 units of the medication Candesartan Cilexetil 16 mg tablets. The contract has a delivery order structure and a firm fixed price pricing type, with a period of performance running through November 20, 2024. This award is not designated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,161.92, is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets. This order is not set aside for any specific business types. The award has an ultimate completion date of August 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,009.82 firm fixed-price delivery order is for the supply of 4,567,089,477 units of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. This contract is not designated under any set-aside program. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $36,318.43 and an ultimate completion date of July 18, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide these essential medication supplies to support military treatment facilities and federal...